首页> 外文学位 >Reducing product costs, increasing raw materials of non-controversial stem cell pharmaceuticals by lean waste elimination: A study with implications for reducing healthcare costs.
【24h】

Reducing product costs, increasing raw materials of non-controversial stem cell pharmaceuticals by lean waste elimination: A study with implications for reducing healthcare costs.

机译:减少产品成本,通过消除瘦肉废物来增加无争议的干细胞药物原料:这项研究对降低医疗成本具有重要意义。

获取原文
获取原文并翻译 | 示例

摘要

A direct cost of a product is the cost of the raw materials used in its manufacturer. When availability of raw materials is high, product cost tend to be lower whereas the inverse occurs when raw materials are low causing product cost to be high. This relationship between product cost and raw material availability holds true regardless of the type of product. The same is true for lifesaving medical treatments produced from stem cells.;This work was used to evaluate balancing measures aimed at increasing the supply of non-controversial stem cells in the production of pharmaceuticals. Reduction in associated product cost was also assessed. The strategy used was the elimination of waste in the manufacturing processes of non-controversial stem cells by application of lean manufacturing. Lean manufacturing is a management technology based on the systemic elimination of waste that has been shown to optimize resources producing high quality products at the lowest cost.;The results of this study examined the influence of the application of lean waste elimination on the availability of raw materials used for production of non-controversial stem cell pharmaceuticals and the associated product cost used for medical treatments in healthcare. The results were positive influences on raw materials with an increase in availability and a significant reduction in the associated cost of the stem cell pharmaceutical product. The latter holds implications of the potential of this study to be used as a point of consideration for evaluating measures to reduce healthcare costs.;Stem cells are used in the production processes of medical treatments where the vast potential continues to remarkably emerge. However, a major problem in advances in stem cell treatments is lack of available raw materials, to include non-controversial stem cell materials affecting production and product costs. An increase in supply could reverse these affects.
机译:产品的直接成本是其制造商使用的原材料的成本。当原材料的可用性高时,产品成本趋于降低,而当原材料的价格低时则相反,从而导致产品成本高。无论产品类型如何,产品成本和原材料可用性之间的这种关系都成立。用干细胞生产的救生医学也是如此。这项工作用于评估旨在增加药品生产中无争议干细胞供应的平衡措施。还评估了相关产品成本的降低。采用的策略是通过应用精益生产来消除无争议干细胞生产过程中的浪费。精益生产是一种基于系统消除废物的管理技术,已被证明可以优化以最低成本生产高品质产品的资源。这项研究的结果检验了应用稀薄废物消除对原料可得性的影响用于生产无争议干细胞药物的材料以及用于医疗保健的相关产品成本。结果对原料产生了积极影响,增加了可用性,并显着降低了干细胞药物产品的相关成本。后者暗示了这项研究的潜力,可以作为评估降低医疗费用的措施的考虑点。干细胞被用于医疗生产过程中,而巨大的潜力仍在继续出现。然而,干细胞治疗进展中的主要问题是缺乏可用的原材料,以包括影响生产和产品成本的无争议的干细胞材料。供应增加可能会扭转这些影响。

著录项

  • 作者

    Gray, Janett.;

  • 作者单位

    Indiana State University.;

  • 授予单位 Indiana State University.;
  • 学科 Biomedical engineering.
  • 学位 Ph.D.
  • 年度 2008
  • 页码 212 p.
  • 总页数 212
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号